Targeted Multispectral Filter Array Design for Endoscopic Cancer Detection in the Gastrointestinal Tract

Colour differences between healthy and diseased tissue in the gastrointestinal tract are detected visually by clinicians during white light endoscopy (WLE); however, the earliest signs of disease are often just a slightly different shade of pink compared to healthy tissue. Here, we propose to target alternative colours for imaging to improve contrast using custom multispectral filter arrays (MSFAs) that could be deployed in an endoscopic chip-on-tip configuration. Using an open-source toolbox, Opti-MSFA, we examined the optimal design of MSFAs for early cancer detection in the gastrointestinal tract. The toolbox was first extended to use additional classification models (k-Nearest Neighbour, Support Vector Machine, and Spectral Angle Mapper). Using input spectral data from published clinical trials examining the oesophagus and colon, we optimised the design of MSFAs with 3 to 9 different bands. We examined the variation of the spectral and spatial classification accuracy as a function of number of bands. The MSFA designs have high classification accuracies, suggesting that future implementation in endoscopy hardware could potentially enable improved early detection of disease in the gastrointestinal tract during routine screening and surveillance. Optimal MSFA configurations can achieve similar classification accuracies as the full spectral data in an implementation that could be realised in far simpler hardware. The reduced number of spectral bands could enable future deployment of multispectral imaging in an endoscopic chip-on-tip configuration.

Reconsidering evaluation practices in modular systems: On the propagation of errors in MRI prostate cancer detection

Magnetic resonance imaging has evolved as a key component for prostate cancer (PCa) detection, substantially increasing the radiologist workload. Artificial intelligence (AI) systems can support radiological assessment by segmenting and classifying lesions in clinically significant (csPCa) and non-clinically significant (ncsPCa). Commonly, AI systems for PCa detection involve an automatic prostate segmentation followed by the lesion detection using the extracted prostate. However, evaluation reports are typically presented in terms of detection under the assumption of the availability of a highly accurate segmentation and an idealistic scenario, omitting the propagation of errors between modules. For that purpose, we evaluate the effect of two different segmentation networks (s1 and s2) with heterogeneous performances in the detection stage and compare it with an idealistic setting (s1:89.90+-2.23 vs 88.97+-3.06 ncsPCa, P<.001, 89.30+-4.07 and 88.12+-2.71 csPCa, P<.001). Our results depict the relevance of a holistic evaluation, accounting for all the sub-modules involved in the system.

Breast cancer detection using deep learning

Objective: This paper proposes a deep learning model for breast cancer detection from reconstructed images of microwave imaging scan data and aims to improve the accuracy and efficiency of breast tumor detection, which could have a significant impact on breast cancer diagnosis and treatment. Methods: Our framework consists of different convolutional neural network (CNN) architectures for feature extraction and a region-based CNN for tumor detection. We use 7 different architectures: DenseNet201, ResNet50, InceptionV3, InceptionResNetV3, MobileNetV2, NASNetMobile and NASNetLarge and compare its performance to find the best architecture out of the seven. An experimental dataset of MRI-derived breast phantoms was used. Results: NASNetLarge is the best architecture which can be used for the CNN model with accuracy of 88.41% and loss of 27.82%. Given that the model's AUC is 0.786, it can be concluded that it is suitable for use in its present form, while it could be improved upon and trained on other datasets that are comparable. Impact: One of the main causes of death in women is breast cancer, and early identification is essential for enhancing the results for patients. Due to its non-invasiveness and capacity to produce high-resolution images, microwave imaging is a potential tool for breast cancer screening. The complexity of tumors makes it difficult to adequately detect them in microwave images. The results of this research show that deep learning has a lot of potential for breast cancer detection in microwave images

TransReg: Cross-transformer as auto-registration module for multi-view mammogram mass detection

Screening mammography is the most widely used method for early breast cancer detection, significantly reducing mortality rates. The integration of information from multi-view mammograms enhances radiologists' confidence and diminishes false-positive rates since they can examine on dual-view of the same breast to cross-reference the existence and location of the lesion. Inspired by this, we present TransReg, a Computer-Aided Detection (CAD) system designed to exploit the relationship between craniocaudal (CC), and mediolateral oblique (MLO) views. The system includes cross-transformer to model the relationship between the region of interest (RoIs) extracted by siamese Faster RCNN network for mass detection problems. Our work is the first time cross-transformer has been integrated into an object detection framework to model the relation between ipsilateral views. Our experimental evaluation on DDSM and VinDr-Mammo datasets shows that our TransReg, equipped with SwinT as a feature extractor achieves state-of-the-art performance. Specifically, at the false positive rate per image at 0.5, TransReg using SwinT gets a recall at 83.3% for DDSM dataset and 79.7% for VinDr-Mammo dataset. Furthermore, we conduct a comprehensive analysis to demonstrate that cross-transformer can function as an auto-registration module, aligning the masses in dual-view and utilizing this information to inform final predictions. It is a replication diagnostic workflow of expert radiologists

Histopathological Cancer Detection Using Hybrid Quantum Computing

We present an effective application of quantum machine learning in the field of healthcare. The study here emphasizes on a classification problem of a histopathological cancer detection using quantum transfer learning. Rather than using single transfer learning model, the work model presented here consists of multiple transfer learning models especially ResNet18, VGG-16, Inception-v3, AlexNet and several variational quantum circuits (VQC) with high expressibility. As a result, we provide a comparative analysis of the models and the best performing transfer learning model with the prediction AUC of approximately 93 percent for histopathological cancer detection. We also observed that for 1000 images with Resnet18, Hybrid Quantum and Classical (HQC) provided a slightly better accuracy of 88.5 percent than classical of 88.0 percent.

Synthetic Data as Validation

This study leverages synthetic data as a validation set to reduce overfitting and ease the selection of the best model in AI development. While synthetic data have been used for augmenting the training set, we find that synthetic data can also significantly diversify the validation set, offering marked advantages in domains like healthcare, where data are typically limited, sensitive, and from out-domain sources (i.e., hospitals). In this study, we illustrate the effectiveness of synthetic data for early cancer detection in computed tomography (CT) volumes, where synthetic tumors are generated and superimposed onto healthy organs, thereby creating an extensive dataset for rigorous validation. Using synthetic data as validation can improve AI robustness in both in-domain and out-domain test sets. Furthermore, we establish a new continual learning framework that continuously trains AI models on a stream of out-domain data with synthetic tumors. The AI model trained and validated in dynamically expanding synthetic data can consistently outperform models trained and validated exclusively on real-world data. Specifically, the DSC score for liver tumor segmentation improves from 26.7% (95% CI: 22.6%-30.9%) to 34.5% (30.8%-38.2%) when evaluated on an in-domain dataset and from 31.1% (26.0%-36.2%) to 35.4% (32.1%-38.7%) on an out-domain dataset. Importantly, the performance gain is particularly significant in identifying very tiny liver tumors (radius < 5mm) in CT volumes, with Sensitivity improving from 33.1% to 55.4% on an in-domain dataset and 33.9% to 52.3% on an out-domain dataset, justifying the efficacy in early detection of cancer. The application of synthetic data, from both training and validation perspectives, underlines a promising avenue to enhance AI robustness when dealing with data from varying domains.

Gall Bladder Cancer Detection from US Images with Only Image Level Labels

Automated detection of Gallbladder Cancer (GBC) from Ultrasound (US) images is an important problem, which has drawn increased interest from researchers. However, most of these works use difficult-to-acquire information such as bounding box annotations or additional US videos. In this paper, we focus on GBC detection using only image-level labels. Such annotation is usually available based on the diagnostic report of a patient, and do not require additional annotation effort from the physicians. However, our analysis reveals that it is difficult to train a standard image classification model for GBC detection. This is due to the low inter-class variance (a malignant region usually occupies only a small portion of a US image), high intra-class variance (due to the US sensor capturing a 2D slice of a 3D object leading to large viewpoint variations), and low training data availability. We posit that even when we have only the image level label, still formulating the problem as object detection (with bounding box output) helps a deep neural network (DNN) model focus on the relevant region of interest. Since no bounding box annotations is available for training, we pose the problem as weakly supervised object detection (WSOD). Motivated by the recent success of transformer models in object detection, we train one such model, DETR, using multi-instance-learning (MIL) with self-supervised instance selection to suit the WSOD task. Our proposed method demonstrates an improvement of AP and detection sensitivity over the SOTA transformer-based and CNN-based WSOD methods. Project page is at https://gbc-iitd.github.io/wsod-gbc

Point Projection Mapping System for Tracking, Registering, Labeling and Validating Optical Tissue Measurements

Validation of newly developed optical tissue sensing techniques for tumor detection during cancer surgery requires an accurate correlation with histological results. Additionally, such accurate correlation facilitates precise data labeling for developing high-performance machine-learning tissue classification models. In this paper, a newly developed Point Projection Mapping system will be introduced, which allows non-destructive tracking of the measurement locations on tissue specimens. Additionally, a framework for accurate registration, validation, and labeling with histopathology results is proposed and validated on a case study. The proposed framework provides a more robust and accurate method for tracking and validation of optical tissue sensing techniques, which saves time and resources compared to conventional techniques available.

ANNCRIPS: Artificial Neural Networks for Cancer Research In Prediction & Survival

Prostate cancer is a prevalent malignancy among men aged 50 and older. Current diagnostic methods primarily rely on blood tests, PSA:Prostate-Specific Antigen levels, and Digital Rectal Examinations (DRE). However, these methods suffer from a significant rate of false positive results. This study focuses on the development and validation of an intelligent mathematical model utilizing Artificial Neural Networks (ANNs) to enhance the early detection of prostate cancer. The primary objective of this research paper is to present a novel mathematical model designed to aid in the early detection of prostate cancer, facilitating prompt intervention by healthcare professionals. The model's implementation demonstrates promising potential in reducing the incidence of false positives, thereby improving patient outcomes. Furthermore, we envision that, with further refinement, extensive testing, and validation, this model can evolve into a robust, marketable solution for prostate cancer detection. The long-term goal is to make this solution readily available for deployment in various screening centers, hospitals, and research institutions, ultimately contributing to more effective cancer screening and patient care.

Computational Pathology at Health System Scale -- Self-Supervised Foundation Models from Three Billion Images

Recent breakthroughs in self-supervised learning have enabled the use of large unlabeled datasets to train visual foundation models that can generalize to a variety of downstream tasks. While this training paradigm is well suited for the medical domain where annotations are scarce, large-scale pre-training in the medical domain, and in particular pathology, has not been extensively studied. Previous work in self-supervised learning in pathology has leveraged smaller datasets for both pre-training and evaluating downstream performance. The aim of this project is to train the largest academic foundation model and benchmark the most prominent self-supervised learning algorithms by pre-training and evaluating downstream performance on large clinical pathology datasets. We collected the largest pathology dataset to date, consisting of over 3 billion images from over 423 thousand microscopy slides. We compared pre-training of visual transformer models using the masked autoencoder (MAE) and DINO algorithms. We evaluated performance on six clinically relevant tasks from three anatomic sites and two institutions: breast cancer detection, inflammatory bowel disease detection, breast cancer estrogen receptor prediction, lung adenocarcinoma EGFR mutation prediction, and lung cancer immunotherapy response prediction. Our results demonstrate that pre-training on pathology data is beneficial for downstream performance compared to pre-training on natural images. Additionally, the DINO algorithm achieved better generalization performance across all tasks tested. The presented results signify a phase change in computational pathology research, paving the way into a new era of more performant models based on large-scale, parallel pre-training at the billion-image scale.